These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18689151)

  • 21. Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.
    Leithner K; Stacher E; Wurm R; Ploner F; Quehenberger F; Wohlkoenig C; Bálint Z; Polachova J; Olschewski A; Samonigg H; Popper HH; Olschewski H
    Lung Cancer; 2009 Jul; 65(1):98-104. PubMed ID: 19081160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
    Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
    Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS
    Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer.
    Hansen LV; Skov BG; Ploug M; Pappot H
    Lung Cancer; 2007 Nov; 58(2):260-6. PubMed ID: 17706320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.
    Soria JC; Jang SJ; Khuri FR; Hassan K; Liu D; Hong WK; Mao L
    Cancer Res; 2000 Aug; 60(15):4000-4. PubMed ID: 10945597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A
    Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of expression of p53 oncoprotein in primary (stage I-IIIa) non-small cell lung cancer.
    Tan DF; Li Q; Rammath N; Beck A; Wiseman S; Anderson T; al-Salameh A; Brooks J; Bepler G
    Anticancer Res; 2003; 23(2C):1665-72. PubMed ID: 12820438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y
    Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer.
    Kawaguchi T; Sho M; Tojo T; Yamato I; Nomi T; Hotta K; Hamada K; Suzaki Y; Sugiura S; Kushibe K; Nakajima Y; Taniguchi S
    Jpn J Clin Oncol; 2010 Apr; 40(4):319-26. PubMed ID: 20085909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
    Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
    J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer.
    Brabender J; Danenberg KD; Metzger R; Schneider PM; Lord RV; Groshen S; Tsao-Wei DD; Park J; Salonga D; Hölscher AH; Danenberg PV
    Clin Cancer Res; 2002 Feb; 8(2):438-43. PubMed ID: 11839661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma.
    Poncelet AJ; Cornet J; Coulon C; Collard P; Noirhomme P; Weynand B;
    Eur J Cardiothorac Surg; 2008 May; 33(5):799-804. PubMed ID: 18374590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer.
    Albert JM; Gonzalez A; Massion PP; Chen H; Olson SJ; Shyr Y; Diaz R; Lambright ES; Sandler A; Carbone DP; Putnam JB; Johnson DH; Lu B
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1845-51. PubMed ID: 17855704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bcl-2 protein expression correlates with better prognosis in patients with advanced non-small cell lung cancer.
    Shibata Y; Hidaka S; Tagawa Y; Nagayasu T
    Anticancer Res; 2004; 24(3b):1925-8. PubMed ID: 15274378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maspin expression and its clinical significance in non-small cell lung cancer.
    Nakagawa M; Katakura H; Adachi M; Takenaka K; Yanagihara K; Otake Y; Wada H; Tanaka F
    Ann Surg Oncol; 2006 Nov; 13(11):1517-23. PubMed ID: 17009165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A lack of prognostic significance regarding DeltaNp63 immunoreactivity in lung cancer.
    Iwata T; Uramoto H; Sugio K; Fujino Y; Oyama T; Nakata S; Ono K; Morita M; Yasumoto K
    Lung Cancer; 2005 Oct; 50(1):67-73. PubMed ID: 15950316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of deltaNp73 predicts poor prognosis in lung cancer.
    Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Morita M; Funa K; Yasumoto K
    Clin Cancer Res; 2004 Oct; 10(20):6905-11. PubMed ID: 15501968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer.
    Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B
    Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.